Here is an update on recent en banc activity at the Federal Circuit in patent cases. Since our last update the court denied a petition that raised a question related to the written description requirement. That’s it. Here are the details.
En Banc Petitions
New Denial
The Federal Circuit denied the petition for hearing en banc in Juno Therapeutics, Inc. v. Kite Pharma, Inc., which raised a question related to the written description requirement.